Is Acusphere, Inc. (ACUS) a Buy, Sell, or Hold?
Acusphere, Inc.
OTC:ACUS
$0.00001 USD
$0 (0.0%)
- Volume
- 125
- Average Volume
- 82
- Market Capitalization
- $49
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $-0.04
- Current Ratio
- $1.45
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | William I. Ramage D.Phil |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | ACUS |
| CUSIP | 00511R854 |
| CIK | 0001115143 |
| Web | https://www.acusphere.com |
| Phone | 617-648-8800 |
| Currency | USD |
| Employees | 50 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.76 |
| Payout Ratio | -0.04 |
| Current Ratio | 1.45 |
| Quick Ratio | 1.45 |
| Cash Ratio | 1.39 |
Sales & Book Value
| Annual Sales | $2.67M |
| Price / Sales | 0.00 |
| Cash Flow | -10.02 |
| Price / Cash Flow | 0.00 |
| Price / Book | 0.00 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-12.6 |
| Trailing P/E Ratio | 0.00 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-53.73M |
| Net Margin | -2014.62% |
| Pretax Margin | 1929.66% |
| Return on Equity | -130.75% |
| Return on Assets | -103.29% |
Financials Score
| AltmanZ Score | -30.04 |
| Piotroski Score | 3.00 |
| Working Capital | -13.93M |
| Total Assets | 22.8M |
| Ebit | -46.43M |
| Market Cap | 49 |
| Total Liabilities | 33.13M |
Poll Results
About Acusphere, Inc. (OTC:ACUS) Stock
Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease. This drug is administered as an injectable suspension. Initially established as Polymers For Medicine, Inc., the organization rebranded as Acusphere, Inc. in March 2004. Founded in 1993, the company maintains its headquarters in Watertown, Massachusetts. ...
Frequently Asked Questions
-
What is the current Acusphere, Inc. (ACUS) stock price?
-
Acusphere, Inc.(OTC:ACUS) stock price is $0.00001 in the last trading session. During the trading session, ACUS stock reached the peak price of $0.00001 while $0.000001 was the lowest point it dropped to. The percentage change in ACUS stock occurred in the recent session was 0.0% while the dollar amount for the price change in ACUS stock was $0.
-
ACUS's industry and sector of operation?
-
The OTC listed ACUS is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of ACUS?
-
William I. Ramage D.Phil | Chief Development Officer
|
|
|
| -
How many employees does ACUS have?
-
Number of ACUS employees currently stands at 50. ACUS operates from 500 Arsenal Street, Watertown, MA 02472, US.
-
Link for ACUS official website?
-
Official Website of ACUS is: https://www.acusphere.com
-
How do I contact ACUS?
-
ACUS could be contacted at phone #617-648-8800 and can also be accessed through its website. ACUS operates from 500 Arsenal Street, Watertown, MA 02472, US.
-
How many shares of ACUS are traded daily?
-
The average number of ACUS shares traded daily for last 3 months was 82.
-
What is the market cap of ACUS currently?
-
The market value of ACUS currently stands at $49 with its latest stock price at $0.00001